View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) Mercks Keytruda retains throne with US$ 29.5 bn in sales, as Novos semaglutide nips at its heels Moving on to drugs, Mercks Keytruda (pembrolizumab) solidified its position as the worlds top-selling pharmaceutical product with sales exceeding US$ 29.5 billion and year-on-year growth of 17.88 percent (US$ 4.5 billion)
For him, it wasnt about endorsements but about solving access problems
In This Article Jack&Jill is fully virtual Jack&Jills main goal is to make healthcare more accessible and affordable
If youre exploring whether medication or surgery is more appropriate, this guide on why Wegovy and Ozempic arent replacements for weight loss surgery explains the differences in expected results and long-term strategy
Get the next one in your inbox I cover the latest GLP-1 trials and access changes weekly
Food and beverage companies, faced with growing pressure from the increased accessibility of appetite-suppressing pills, are reformulating around the GLP-1 consumer who eats less but cares more about protein, fiber and how food makes them feel there is even now more protein in your Pop-Tarts